Search - tctmd.com

Displaying 1 - 20 of 170

Sort: Relevancy | Date

News Conference News AHA 2025

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

Caitlin E. Cox

November 14, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

TCT 810: Classifying Coronary Microvascular Dysfunction and Vasospastic Angina after Comprehensive Invasive Functional Testing: Characterizing Coronary Endotypes

Presenter: Ronney Shantouf

October 28, 2025

Presentation TCT 2025

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

Presenter: Jingpu Wang

October 28, 2025

Presentation TCT 2025

TCT 805: Coronary Microvascular Dysfunction or Adaptive Physiology? Exploring Baseline Resistance in Preserved Flow Reserve and Elevated Hyperemic Resistance

Presenter: Timo Nijkamp

October 27, 2025

Presentation TCT 2025

TCT 795: Prognostic Implications of Microvascular Dysfunction and the Coronary Flow Velocity Ratio AfterElective Percutaneous Coronary Intervention

Presenter: Pedro Jallad

October 27, 2025

Presentation TCT 2025

TCT 791: Coronary Sinus Narrowing for the Treatment of Patients with Angina Caused by Microvascular Dysfunction

Presenter: Maayan Konigstein

October 26, 2025

Presentation TCT 2025

TCT 778: Dynamic CT Perfusion Versus Quantitative Stress CMR in Detecting Coronary Microvascular Dysfunction: a Sub-analysis of the ADVANTAGE II Study

Presenter: Stefano Galli

October 26, 2025

Presentation TCT 2025

TCT 781: Combined High-Frequency Optical Coherence Tomography and Coronary Microvascular Dysfunction Evaluation for Cardiac Allograft Vasculopathy

Presenter: Vivek Mehta

October 26, 2025

Presentation TCT 2025

Diagnosing Coronary Microvascular Dysfunction Patients

Presenter: Khaled Ziada

October 26, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

Presentation TCT 2024

TCT 606: Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction

Presenter: Waiel Abusnina

October 30, 2024

Presentation TCT 2024

TCT 605: Prevalence of Coronary Microvascular Dysfunction and Vasomotor Abnormalities in Patients With History of Coronary Revascularization

Presenter: Chaitanya Chennareddy

October 30, 2024

Presentation TCT 2024

TCT 602: Association Between the Severity of Coronary Artery Stenosis With the Minimum Responsive Dose of Intracoronary Provocation Test

Presenter: Woo Jin Ahn

October 30, 2024

Advertisement

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

TCT 810: Classifying Coronary Microvascular Dysfunction and Vasospastic Angina after Comprehensive Invasive Functional Testing: Characterizing Coronary Endotypes

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

TCT 805: Coronary Microvascular Dysfunction or Adaptive Physiology? Exploring Baseline Resistance in Preserved Flow Reserve and Elevated Hyperemic Resistance

TCT 795: Prognostic Implications of Microvascular Dysfunction and the Coronary Flow Velocity Ratio AfterElective Percutaneous Coronary Intervention

TCT 791: Coronary Sinus Narrowing for the Treatment of Patients with Angina Caused by Microvascular Dysfunction

TCT 778: Dynamic CT Perfusion Versus Quantitative Stress CMR in Detecting Coronary Microvascular Dysfunction: a Sub-analysis of the ADVANTAGE II Study

TCT 781: Combined High-Frequency Optical Coherence Tomography and Coronary Microvascular Dysfunction Evaluation for Cardiac Allograft Vasculopathy

Diagnosing Coronary Microvascular Dysfunction Patients

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Early Coronary Function Testing Improves Quality of Life in ANOCA

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Cannabis Use Again Tied to Increased CVD Risk in Young People

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

TCT 606: Epicardial Fat Tissue: A Potential Marker for Coronary Microvascular Dysfunction

TCT 605: Prevalence of Coronary Microvascular Dysfunction and Vasomotor Abnormalities in Patients With History of Coronary Revascularization

TCT 602: Association Between the Severity of Coronary Artery Stenosis With the Minimum Responsive Dose of Intracoronary Provocation Test

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content